KHURRUM PIRZADA: Open Payments
NPI 1750304119 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,233 in 60 payments from 12 companies in 2025. Trend: 2023 $979 · 2024 $1,428 · 2025 $2,233
Food & beverage: $2,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $719 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $586 |
| Lilly USA, LLC | 4 | $258 |
| Axsome Therapeutics, Inc. | 4 | $170 |
| Indivior Inc. | 3 | $156 |
| Vanda Pharmaceuticals Inc. | 5 | $152 |
| Braeburn Inc. | 4 | $80 |
| Novo Nordisk Inc | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, UBRELVY, Auvelity, SUBLOCADE, FANAPT, QULIPTA, MOUNJARO.
Industry payments across MI — which companies pay providers there.
